89 related articles for article (PubMed ID: 394311)
1. Continuous blood glucose monitoring and characteristics of diabetes in patients on maintenance haemodialysis treatment.
Pitkänen E; Koivula T
Scand J Urol Nephrol; 1979; 13(3):309-12. PubMed ID: 394311
[TBL] [Abstract][Full Text] [Related]
2. [Intermittent peritoneal chronic dialysis in diabetic patients: effect of the technique on blood glucose and protein loss during the procedure].
García Ortiz R; Gómez M; Olea C
Rev Med Chil; 1989 Dec; 117(12):1367-73. PubMed ID: 2519375
[TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus: new approaches to complications.
Maxwell DR; Luft FC; Clark CM; Vinicor F
J Indiana State Med Assoc; 1982 Mar; 75(3):184-6. PubMed ID: 7042851
[No Abstract] [Full Text] [Related]
4. Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease.
Amair P; Khanna R; Leibel B; Pierratos A; Vas S; Meema E; Blair G; Chisolm L; Vas M; Zingg W; Digenis G; Oreopoulos D
N Engl J Med; 1982 Mar; 306(11):625-30. PubMed ID: 7035945
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of continuous glucose monitoring in dialysis patients with diabetes: the DIALYDIAB pilot study.
Joubert M; Fourmy C; Henri P; Ficheux M; Lobbedez T; Reznik Y
Diabetes Res Clin Pract; 2015 Mar; 107(3):348-54. PubMed ID: 25638452
[TBL] [Abstract][Full Text] [Related]
6. [Metabolic parameters of CAPD and CCPD in diabetics with terminal renal insufficiency].
Thomae U; Kuhlmann H; Herrmann M; Büchele W
Dtsch Med Wochenschr; 1984 Jun; 109(24):941-4. PubMed ID: 6734446
[TBL] [Abstract][Full Text] [Related]
7. Continuous interstitial glucose monitoring in non-diabetic subjects with end-stage renal disease undergoing maintenance haemodialysis.
Sobngwi E; Ashuntantang G; Ndounia E; Dehayem M; Azabji-Kenfack M; Kaze F; Balti E; Mbanya JC
Diabetes Res Clin Pract; 2010 Oct; 90(1):22-5. PubMed ID: 20705354
[TBL] [Abstract][Full Text] [Related]
8. The management of terminal renal failure in diabetic patients by regular dialysis therapy.
White N; Snowden SA; Parsons V; Sheldon J; Bewick M
Nephron; 1973; 11(5):261-75. PubMed ID: 4753518
[No Abstract] [Full Text] [Related]
9. [The significance of compensation in diabetes mellitus in the development of diabetic microangiopathies (a review of the literature)].
Gendeleka GF
Vrach Delo; 1989 Aug; (8):54-8. PubMed ID: 2686158
[No Abstract] [Full Text] [Related]
10. [Terminal renal insufficiency and diabetes].
Coronel Díaz F; Naranjo Gómez P; Alvarez Otero MJ; Prats Sánchez D
Rev Clin Esp; 1983 May; 169(4):221-8. PubMed ID: 6353495
[No Abstract] [Full Text] [Related]
11. Serum insulin, glucose, and lipid levels among mild diabetics in relation to incidence of vascular complications.
Elkeles RS; Lowy C; Wyllie AD; Young JL; Fraser TR
Lancet; 1971 May; 1(7705):880-3. PubMed ID: 4102026
[No Abstract] [Full Text] [Related]
12. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
[TBL] [Abstract][Full Text] [Related]
13. Effect of acetate on blood metabolites and glucose tolerance during haemodialysis in uraemic non-diabetic and diabetic subjects.
Akanji AO; Sacks S
Nephron; 1991; 57(2):137-43. PubMed ID: 2020339
[TBL] [Abstract][Full Text] [Related]
14. [Advantages of insulin Lispro (short-acting) in terminal kidney failure].
Jehle PM; Aisenpreis U; Bundschu D; Keller F
Fortschr Med; 1999 Apr; 117(11):41-2. PubMed ID: 10339922
[TBL] [Abstract][Full Text] [Related]
15. Best practice for diabetic patients on hemodialysis 2012.
Nakao T; Inaba M; Abe M; Kaizu K; Shima K; Babazono T; Tomo T; Hirakata H; Akizawa T;
Ther Apher Dial; 2015 Mar; 19 Suppl 1():40-66. PubMed ID: 25817932
[No Abstract] [Full Text] [Related]
16. [Management of blood glucose in diabetic dialysis patients].
Hori K; Fujimi S
Nihon Rinsho; 1992 Jan; 50 Suppl():192-6. PubMed ID: 1578677
[No Abstract] [Full Text] [Related]
17. Insulin, glucose and lipid levels in mild diabetics in relation to complications.
Fraser R; Lowy C; Elkeles RS; Lewis B; Mancini M
Adv Metab Disord; 1973; 2():Suppl 2:83-101. PubMed ID: 4720391
[No Abstract] [Full Text] [Related]
18. Glucose-added dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis.
Burmeister JE; Scapini A; da Rosa Miltersteiner D; da Costa MG; Campos BM
Nephrol Dial Transplant; 2007 Apr; 22(4):1184-9. PubMed ID: 17272314
[TBL] [Abstract][Full Text] [Related]
19. Different risk factors for peripheral vascular calcification between diabetic and non-diabetic haemodialysis patients--importance of glycaemic control.
Ishimura E; Okuno S; Kitatani K; Kim M; Shoji T; Nakatani T; Inaba M; Nishizawa Y
Diabetologia; 2002 Oct; 45(10):1446-8. PubMed ID: 12378387
[TBL] [Abstract][Full Text] [Related]
20. A new method of post-dialysis blood urea sampling: the 'stop dialysate flow' method.
Geddes CC; Traynor J; Walbaum D; Fox JG; Mactier RA
Nephrol Dial Transplant; 2000 Apr; 15(4):517-23. PubMed ID: 10727547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
